Sabra Healthcare REIT Inc (NASDAQ:SBRA) currently has a daily average trading volume of 2.09M but it saw 2290391 shares traded in last market. With a market cap of 3.90B USD, the company’s current market price of $16.39 came falling about -0.18 while comparing to the previous closing price of $16.42. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.99 and as low as $13.22.
Taking a look at 20-day trading activity of Sabra Healthcare REIT Inc (SBRA) gives us an average price of $16.51, while its current price level is -18.02% below from 52-week high level whereas it is 23.99% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $16.82 while that of 200 days or SMA-200 reads an average of $16.86. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.83% during that period while stretching the period over a month that decreases to 2.86%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.58 which implies that the stock is in neutral territory.
JMP Securities upgraded its recommendation for the stock as a “Mkt Outperform” from “Mkt Perform” on January 07, 2025 while assigning a price target of $20. Mizuho also issued its recommendations for the stock as it downgraded the price target for the stock is $20.
Over the week, SBRA’s stock price is moving -0.97% down while it is -6.02% when we observe its performance for the past one month. Year-to-date it is -5.37% down and over the past year, the stock is showing an upside performance of 18.09%.
Currently, Sabra Healthcare REIT Inc’s total number of outstanding shares is 237.59M. Company’s return on investment (ROI) stands at 2.44% and return on equity (ROE) at 4.57%. It has a price to earnings ratio (P/E ratio) of 30.60 while having a 20.83 of forward P/E ratio. Stock’s beta reads 1.25. Stock has a price to book (P/B) ratio of 1.42 while price to sale or P/S ratio amounts to 5.56. Its return on asset (ROA) is 2.37% on average.
